From $49 to $110: Why Piper Sandler Thinks CRSP Can More Than Double From Here [Yahoo! Finance]
Piper Sandler Companies (PIPR)
Last piper sandler companies earnings: 5/1 08:04 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
through clinical development without near-term capital raises. CASGEVY gene therapy generated $116M in 2025 revenue with patient initiations nearly tripling year-over-year, and a pediatric label expansion (ages 5-11) with regulatory submissions expected in H1 2026 could expand the addressable market. CTX310 demonstrated strong early cardiovascular results published in the New England Journal of Medicine and is advancing to Phase 1b. Piper Sandler raised its price target to $110 (implying 120% upside) based on CRSP's extended cash runway enabling simultaneous advancement of multiple pipeline programs and accelerating CASGEVY commercial traction with upcoming pediatric label expansion. A recent study identified one single habit that doubled Americans' retirement savings and moved retirement from dream, to reality. Read more here CRISPR Therapeutics NASDAQ:CRSP ) has had a rough stretch lately. Shares have dropped 5% over the past week and are down 8% year-to-date, trading around $
Show less
Read more
Impact Snapshot
Event Time:
PIPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PIPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PIPR alerts
High impacting Piper Sandler Companies news events
Weekly update
A roundup of the hottest topics
PIPR
News
- Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Cybersecurity CEO Summit Sets The Tone For An AI-Defined RSAC [Yahoo! Finance]Yahoo! Finance
- This Cathie Wood Stock Is Down 36% Over the Past 2 Years. She Still Can't Get Enough. [Yahoo! Finance]Yahoo! Finance
- A Wall Street analyst flags 3 'toxic' forces pushing the stock market toward a tipping point [Yahoo! Finance]Yahoo! Finance
- A Wall Street analyst flags 3 'toxic' forces pushing the stock market toward a tipping point [Business Insider]Business Insider
PIPR
Earnings
- 2/6/26 - Beat
PIPR
Sec Filings
- 3/20/26 - Form ARS
- 3/16/26 - Form 4
- 3/16/26 - Form 4
- PIPR's page on the SEC website